PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19912061-0	2009	Inhibition of carnitine acetyltransferase by mildronate, a regulator of energy metabolism.	3-(2,2,2-trimethylhydrazine)propionate	45-55	carnitine O-acetyltransferase	Homo sapiens	14-41	
19912061-2	2009	In this study, biochemical measurements, saturation transfer difference (STD) nuclear magnetic resonance (NMR) spectroscopy, and molecular docking were applied to give insights into the CrAT binding of a synthetic inhibitor, the cardioprotective drug mildronate (3-(2,2,2-trimethylhydrazinium)-propionate).	3-(2,2,2-trimethylhydrazine)propionate	251-261	carnitine O-acetyltransferase	Homo sapiens	186-190	
19912061-2	2009	In this study, biochemical measurements, saturation transfer difference (STD) nuclear magnetic resonance (NMR) spectroscopy, and molecular docking were applied to give insights into the CrAT binding of a synthetic inhibitor, the cardioprotective drug mildronate (3-(2,2,2-trimethylhydrazinium)-propionate).	3-(2,2,2-trimethylhydrazine)propionate	263-304	carnitine O-acetyltransferase	Homo sapiens	186-190	
19912061-3	2009	The obtained results show that mildronate inhibits CrAT in a competitive manner through binding to the carnitine binding site, not the acetyl-CoA binding site.	3-(2,2,2-trimethylhydrazine)propionate	31-41	carnitine O-acetyltransferase	Homo sapiens	51-55	
19912061-5	2009	The dissociation constant of the mildronate CrAT complex is approximately 0.1 mM, and the K(i) is 1.6 mM.	3-(2,2,2-trimethylhydrazine)propionate	33-43	carnitine O-acetyltransferase	Homo sapiens	44-48	
19912061-6	2009	The results suggest that the cardioprotective effect of mildronate might be partially mediated by CrAT inhibition and concomitant regulation of cellular energy metabolism pathways.	3-(2,2,2-trimethylhydrazine)propionate	56-66	carnitine O-acetyltransferase	Homo sapiens	98-102